| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Medical Microbiology, Lund University, Lund, Sweden
All clinical isolates of Streptococcus pyogenes (group A streptococcus) share the ability to resist phagocytosis and grow in human blood. In many strains, this property is due to the expression of a single antiphagocytic M protein, while other strains express more than one M-like molecule, of which the role in phagocytosis resistance is unclear. In particular, all S. pyogenes strains of the OF+ lineage, representing approximately half of all isolates, express two M-like proteins, Mrp and Emm, which are immunologically unrelated. These two proteins bind different ligands that have been implicated in phagocytosis resistance: Mrp binds fibrinogen and Emm binds the complement inhibitor C4BP. Using a clinical isolate of the common serotype 22, we created mutants affected in the mrp and emm genes and characterized them in phagocytosis experiments and by electron microscopy. A double mutant mrp-emm- showed strongly decreased resistance to phagocytosis, while mrp- and emm- single mutants grew well in blood. However, optimal growth required the expression of both Mrp and Emm. Experiments in which coagulation was inhibited using the specific thrombin inhibitor, hirudin, rather than heparin, indicated that Emm is more important than Mrp for resistance to phagocytosis. Tuftlike surface structures typical for S. pyogenes were still present in the mrp-emm- double mutant, but not in a mutant affected in the regulatory gene mga, indicating that the presence of these surface structures is not directly correlated to phagocytosis resistance. Our data imply that OF+ strains of S. pyogenes express two antiphagocytic M proteins with different ligand-binding properties.
This article has been cited by other articles:
|
|
 |
|
  A. C. Almengor, M. S. Walters, and K. S. McIver Mga Is Sufficient To Activate Transcription In Vitro of sof-sfbX and Other Mga-Regulated Virulence Genes in the Group A Streptococcus J. Bacteriol., March 15, 2006; 188(6): 2038 - 2047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Vahling and K. S. McIver Identification of Residues Responsible for the Defective Virulence Gene Regulator Mga Produced by a Natural Mutant of Streptococcus pyogenes J. Bacteriol., September 1, 2005; 187(17): 5955 - 5966. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tenenbaum, C. Bloier, R. Adam, D. J. Reinscheid, and H. Schroten Adherence to and Invasion of Human Brain Microvascular Endothelial Cells Are Promoted by Fibrinogen-Binding Protein FbsA of Streptococcus agalactiae Infect. Immun., July 1, 2005; 73(7): 4404 - 4409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Gutekunst, B. J. Eikmanns, and D. J. Reinscheid The Novel Fibrinogen-Binding Protein FbsB Promotes Streptococcus agalactiae Invasion into Epithelial Cells Infect. Immun., June 1, 2004; 72(6): 3495 - 3504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Carlsson, K. Berggard, M. Stalhammar-Carlemalm, and G. Lindahl Evasion of Phagocytosis through Cooperation between Two Ligand-binding Regions in Streptococcus pyogenes M Protein J. Exp. Med., October 6, 2003; 198(7): 1057 - 1068. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Sandin, S. Linse, T. Areschoug, J. M. Woof, J. Reinholdt, and G. Lindahl Isolation and Detection of Human IgA Using a Streptococcal IgA-Binding Peptide J. Immunol., August 1, 2002; 169(3): 1357 - 1364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Morfeldt, K. Berggard, J. Persson, T. Drakenberg, E. Johnsson, E. Lindahl, S. Linse, and G. Lindahl Isolated Hypervariable Regions Derived from Streptococcal M Proteins Specifically Bind Human C4b-Binding Protein: Implications for Antigenic Variation J. Immunol., October 1, 2001; 167(7): 3870 - 3877. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Blom, A. Rytkonen, P. Vasquez, G. Lindahl, B. Dahlback, and A.-B. Jonsson A Novel Interaction Between Type IV Pili of Neisseria gonorrhoeae and the Human Complement Regulator C4b-Binding Protein J. Immunol., June 1, 2001; 166(11): 6764 - 6770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Blom, K. Berggard, J. H. Webb, G. Lindahl, B. O. Villoutreix, and B. Dahlback Human C4b-Binding Protein Has Overlapping, But Not Identical, Binding Sites for C4b and Streptococcal M Proteins J. Immunol., May 15, 2000; 164(10): 5328 - 5336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kotarsky, A. Thern, G. Lindahl, and U. Sjobring Strain-Specific Restriction of the Antiphagocytic Property of Group A Streptococcal M Proteins Infect. Immun., January 1, 2000; 68(1): 107 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Johnsson, T. Areschoug, J. Mestecky, and G. Lindahl An IgA-binding Peptide Derived from a Streptococcal Surface Protein J. Biol. Chem., May 21, 1999; 274(21): 14521 - 14524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.-M. Kihlberg, M. Collin, A. Olsen, and L. Bjorck Protein H, an Antiphagocytic Surface Protein in Streptococcus pyogenes Infect. Immun., April 1, 1999; 67(4): 1708 - 1714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. W. Navarre and O. Schneewind Surface Proteins of Gram-Positive Bacteria and Mechanisms of Their Targeting to the Cell Wall Envelope Microbiol. Mol. Biol. Rev., March 1, 1999; 63(1): 174 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Johnsson, K. Berggard, H. Kotarsky, J. Hellwage, P. F. Zipfel, U. Sjobring, and G. Lindahl Role of the Hypervariable Region in Streptococcal M Proteins: Binding of a Human Complement Inhibitor J. Immunol., November 1, 1998; 161(9): 4894 - 4901. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kotarsky, J. Hellwage, E. Johnsson, C. Skerka, H. G. Svensson, G. Lindahl, U. Sjobring, and P. F. Zipfel Identification of a Domain in Human Factor H and Factor H-Like Protein-1 Required for the Interaction with Streptococcal M Proteins J. Immunol., April 1, 1998; 160(7): 3349 - 3354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Pleass, T. Areschoug, G. Lindahl, and J. M. Woof Streptococcal IgA-binding Proteins Bind in the Calpha 2-Calpha 3 Interdomain Region and Inhibit Binding of IgA to Human CD89 J. Biol. Chem., March 9, 2001; 276(11): 8197 - 8204. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
